I am a Professor of Surgery, Robert Wood Johnson Medical School and am the Director of the Melanoma and Soft Tissue Oncology Program and one of the original faculty members of the Cancer Institute of New Jersey. I came to the Cancer Institute in 1995 and built the first clinical program focused on the treatment of patients with melanoma, other advanced cancers of the skin, and soft tissue sarcomas in New Jersey. Over the past 17 years I have assembled a multidisciplinary team of physicians, advanced practice nurses, and support personnel at our institution in order to offer patients state-of-the-art therapies and access to cutting-edge treatments. Our program is now one of the largest in the Northeastern United States seeing over 400 new patients with melanoma every year. Our Surgeons perform more operations for the treatment of melanoma, including wide local excisions, sentinel node evaluations, and procedures for more advanced disease, then anyone else in our region. Our team of dedicated medical oncologists, radiation oncologists, and other specialists provide our patients with a comprehensive evaluation and non-surgical treatments as well, some of which are only available at the Cancer Institute of New Jersey.
One of the unique things about providing treatment at a National Cancer Institute-designated Comprehensive Cancer Center is the ability to conduct research that directly translates into patient care. Since completing my training as a Surgical Resident at the University of Connecticut and as a Surgical Oncology Fellow at The University of Pittsburgh I have had a strong interest in melanoma research. I am a National Cancer Institute (NCI)-funded investigator and the leader of a large laboratory team of researchers at our institution focused on melanoma. Many of our laboratory discoveries have been translated into clinical trials for patients with melanoma and we maintain close collaborations with investigators at Rutgers University, Memorial Sloan Kettering Cancer Center, the University of Pennsylvania and many other institutions.
I am the author or co-author of more than 50 publications and serve on the editorial board of the journal Clinical Cancer Research. As a member of the Clinical Oncology Study Section of the National Institutes of Heath I am responsible for reviewing grant applications from institutions all over the country.
Melanoma, other advanced cancers of the skin, and soft tissue sarcomas
To schedule an appointment call 732-235-8515